Bayer CropScience stock has the potential to rise toward ₹12,000 over the next five years, supported by long-term revenue growth and innovations in crop protection and digital farming technologies, according to SEBI-registered research firm Finance With Palak.
At the time of writing, Bayer CropScience shares were trading at ₹5,739.10, up ₹608.30 or 11.86% on the day.
In the short term, the firm expects the stock to reach ₹6,300–₹6,500, backed by ongoing revenue and profit momentum.
The research firm noted that over the medium term (1–2 years), the stock could rise to ₹7,500–₹7,600, with catalysts including increased adoption of sustainable agricultural practices and deeper penetration into emerging markets.
Bayer CropScience shares climbed by 11% after Q4 results due to strong investor interest following the company's disclosure of a 49.27% year-on-year quarterly net profit rise to ₹143.3 crore, paired with a 32% revenue growth from operations.
Finance With Palak said the stock shows key technical support between ₹5,500 and ₹5,600 while facing resistance between ₹5,800 and ₹5,900.
The stock's price stands at ₹5,740.90, with a market capitalization of ₹224.24 billion and a P/E ratio of 43.06.
On Stocktwits, retail sentiment was ‘bullish’ amid ‘high’ message volume.
The stock has risen 3.7% so far in 2025.
For updates and corrections, email newsroom[at]stocktwits[dot]com.